Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-11-17
DOI
10.3389/fimmu.2020.583008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Key Steps in Vaccine Development
- (2020) Peter L. Stern ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia
- (2019) Sarah M. Baker et al. VACCINE
- Immunological considerations in the development of Pseudomonas aeruginosa vaccines
- (2019) Sarah M. Baker et al. Human Vaccines & Immunotherapeutics
- LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) mice
- (2019) E. Valli et al. Scientific Reports
- Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia
- (2019) Emel Sen-Kilic et al. Frontiers in Immunology
- Characterization and Protective Efficacy of Type III Secretion Proteins as a Broadly Protective Subunit Vaccine against Salmonella enterica Serotypes
- (2018) Francisco J. Martinez-Becerra et al. INFECTION AND IMMUNITY
- Immunization with Pseudomonas aeruginosa outer membrane vesicles stimulates protective immunity in mice
- (2018) Xiaoli Zhang et al. VACCINE
- PA0833 Is an OmpA C-Like Protein That Confers Protection Against Pseudomonas aeruginosa Infection
- (2018) Feng Yang et al. Frontiers in Microbiology
- The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
- (2018) John D. Clements et al. mSphere
- The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia
- (2018) Yoshifumi Naito et al. MICROBIOLOGY AND IMMUNOLOGY
- Progress Toward the Elusive Pseudomonas aeruginosa Vaccine
- (2018) Christina Merakou et al. Surgical Infections
- Efficacy comparison of adjuvants in PcrV vaccine againstPseudomonas aeruginosapneumonia
- (2017) Saeko Hamaoka et al. MICROBIOLOGY AND IMMUNOLOGY
- Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis
- (2017) Pauline Basso et al. mBio
- Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection
- (2017) Jonathan Kevin Sia et al. PLoS Pathogens
- Exolysin Shapes the Virulence of Pseudomonas aeruginosa Clonal Outliers
- (2017) Emeline Reboud et al. Toxins
- Interleukin-17 Is Required for Control of Chronic Lung Infection Caused by Pseudomonas aeruginosa
- (2016) Hannah K. Bayes et al. INFECTION AND IMMUNITY
- Targeting the Type Three Secretion System in Pseudomonas aeruginosa
- (2016) Ahalieyah Anantharajah et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- X-ray Irradiated Vaccine Confers protection against Pneumonia caused by Pseudomonas Aeruginosa
- (2016) Yanyan Li et al. Scientific Reports
- Biophysical Characterization of the Type III Secretion System Translocator Proteins and the Translocator Proteins Attached to Bacterium-Like Particles
- (2015) Xiaotong Chen et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Enhanced annotations and features for comparing thousands ofPseudomonasgenomes in the Pseudomonas genome database
- (2015) Geoffrey L. Winsor et al. NUCLEIC ACIDS RESEARCH
- A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models
- (2014) Paul Warrener et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Detergent on Biophysical Properties and Immune Response of the IpaDB Fusion Protein, a Candidate Subunit Vaccine against Shigella Species
- (2014) Xiaotong Chen et al. INFECTION AND IMMUNITY
- Intradermal Delivery of Shigella IpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes
- (2014) S. J. Heine et al. JOURNAL OF IMMUNOLOGY
- Vaccination against respiratoryPseudomonas aeruginosainfection
- (2014) Keith Grimwood et al. Human Vaccines & Immunotherapeutics
- Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
- (2013) Marlies Galle et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Characterization of a Novel Fusion Protein from IpaB and IpaD of Shigella spp. and Its Potential as a Pan-Shigella Vaccine
- (2013) Francisco J. Martinez-Becerra et al. INFECTION AND IMMUNITY
- Studies of the conformational stability of invasion plasmid antigen B fromShigella
- (2013) Shyamal P. Choudhari et al. PROTEIN SCIENCE
- Oligomeric states of theShigellatranslocator protein IpaB provide structural insights into formation of the type III secretion translocon
- (2013) Nicholas E. Dickenson et al. PROTEIN SCIENCE
- Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella
- (2013) Francisco J. Martinez-Becerra et al. VACCINE
- Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD
- (2013) Shannon J. Heine et al. VACCINE
- Th17-stimulating Protein Vaccines Confer Protection againstPseudomonas aeruginosaPneumonia
- (2012) Weihui Wu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The A Subunit of Escherichia coli Heat-Labile Enterotoxin Functions as a Mucosal Adjuvant and Promotes IgG2a, IgA, and Th17 Responses to Vaccine Antigens
- (2012) Elizabeth B. Norton et al. INFECTION AND IMMUNITY
- The Adjuvant Double Mutant Escherichia coli Heat Labile Toxin Enhances IL-17A Production in Human T Cells Specific for Bacterial Vaccine Antigens
- (2012) Susannah Leach et al. PLoS One
- Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins
- (2011) Francisco J. Martinez-Becerra et al. INFECTION AND IMMUNITY
- Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity againstPseudomonas aeruginosaAcute Lung Infection
- (2010) Akinobu Kamei et al. INFECTION AND IMMUNITY
- Polymorphisms in the Pseudomonas aeruginosa type III secretion protein, PcrV – Implications for anti-PcrV immunotherapy
- (2010) Susan V. Lynch et al. MICROBIAL PATHOGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now